A detailed history of Crewe Advisors LLC transactions in Medtronic PLC stock. As of the latest transaction made, Crewe Advisors LLC holds 1,404 shares of MDT stock, worth $121,123. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,404
Previous 1,404 -0.0%
Holding current value
$121,123
Previous $110,000 14.55%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$78.71 - $87.02 $5,903 - $6,526
-75 Reduced 5.07%
1,404 $110,000
Q1 2024

May 13, 2024

BUY
$82.84 - $88.09 $122,520 - $130,285
1,479 New
1,479 $128,000
Q2 2023

Jul 28, 2023

SELL
$79.47 - $91.38 $50,622 - $58,209
-637 Reduced 59.92%
426 $37,000
Q1 2023

May 12, 2023

SELL
$76.72 - $87.58 $28,846 - $32,930
-376 Reduced 26.13%
1,063 $85,000
Q4 2022

Feb 07, 2023

BUY
$76.18 - $87.74 $5,561 - $6,405
73 Added 5.34%
1,439 $111,000
Q3 2022

Nov 14, 2022

BUY
$80.75 - $95.31 $13,646 - $16,107
169 Added 14.12%
1,366 $110,000
Q2 2022

Aug 02, 2022

BUY
$87.4 - $113.09 $64,413 - $83,347
737 Added 160.22%
1,197 $107,000
Q4 2021

Feb 10, 2022

BUY
$99.53 - $127.75 $29,460 - $37,814
296 Added 180.49%
460 $48,000
Q3 2021

Oct 29, 2021

SELL
$122.75 - $135.17 $4,910 - $5,406
-40 Reduced 19.61%
164 $21,000
Q2 2021

Aug 11, 2021

SELL
$118.19 - $131.5 $7,682 - $8,547
-65 Reduced 24.16%
204 $25,000
Q4 2020

Jan 27, 2021

SELL
$100.57 - $117.14 $3,017 - $3,514
-30 Reduced 10.03%
269 $32,000
Q3 2020

Oct 13, 2020

BUY
$90.13 - $108.78 $26,948 - $32,525
299 New
299 $31,000
Q1 2020

May 07, 2020

SELL
$72.92 - $121.3 $2,187 - $3,639
-30 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$104.49 - $114.54 $3,134 - $3,436
30 New
30 $3,000
Q3 2019

Nov 06, 2019

SELL
$98.02 - $111.18 $588 - $667
-6 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$82.45 - $93.79 $494 - $562
6 New
6 $1,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Crewe Advisors LLC Portfolio

Follow Crewe Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.